e-learning
resources
Courses
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Opioids
G. Rocker (Halifax, Canada)
Source:
ERS Online Course 2016
Number:
9
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Rocker (Halifax, Canada). Opioids. ERS Online Course 2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Nermin Ismić - 17.03.2016 10:00
Where is the online version of this lesson?
You must
Login
to comment this presentation.
Related content which might interest you:
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Post partum
dyspnoea: look beyond the lungs
A 34-year-old male smoker with exertional dyspnoea
Related content which might interest you:
Drugs anti-inflammatories
Source: Virtual Congress 2020 – Management
Year: 2020
Targeting neuropetides: from antiemetics to bronchodilators?
Source: Annual Congress 2012 - ERS Romain Pauwels Research Award Ceremony (supported by GlaxoSmithKline) followed by the Hot Topic "The nerves are back!"
Year: 2012
Management of COVID-19: Drugs anti-inflammatories
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021
Ampakine therapy to alleviate opioid and anesthetic induced respiratory depression
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Opiate therapy in chronic cough
Source: Eur Respir J 2005; 26: Suppl. 49, 129s
Year: 2005
Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
Source: Breathe, 15 (2) 137; 10.1183/20734735.0015-2019
Year: 2019
Opioids for chronic refractory breathlessness: patient predictors of beneficial response
Source: Eur Respir J 2013; 42: 758-766
Year: 2013
Drugs anti-virals
Source: Virtual Congress 2020 – Management
Year: 2020
Mucolytics and anti-inflammatory lung treatments
Source: ERS course 2015
Year: 2015
Inappropriate Utilization of Antibiotics in COPD Exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Inhaled anticholinergic drugs and risk of acute urinary retention
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008
Serotonergic antidepressants in COPD: beneficial or harmful?
Source: Eur Respir J, 52 (1) 1801095; 10.1183/13993003.01095-2018
Year: 2018
Non-pharmacological treatments for cough
Source: Annual Congress 2008 - Treating cough
Year: 2008
Medications that induce central sleep apnoea (e.g., opioids, baclofen and ticagrelor)
Source: 5th Sleep and Breathing Conference
Year: 2019
Macrolides as anti-inflammatory agents in CAP
Source: Eur Respir Monogr 2014; 63: 243-255
Year: 2014
Detrimental effects of Beta-blockers in COPD
Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
Year: 2009
Less pain without pain-killers?
Source: Annual Congress 2012 - Special problems in thoracic surgery
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept